...
首页> 外文期刊>Journal of Medicinal Chemistry >Synthesis and structure-activity relationship study of antimicrotubule agents phenylahistin derivatives with a didehydropiperazine-2,5-dione structure
【24h】

Synthesis and structure-activity relationship study of antimicrotubule agents phenylahistin derivatives with a didehydropiperazine-2,5-dione structure

机译:具有双脱氢哌嗪-2,5-二酮结构的抗微管剂苯基组蛋白衍生物的合成及构效关系研究

获取原文
获取原文并翻译 | 示例

摘要

Plinabulin (11, NPI-2358) is a potent microtubule-targeting agent derived from the natural diketopiperazine "phenylahistin" (1) with a colchicine-like tubulin depolymerization activity. Compound 11 was recently developed as VDA and is now under phase II clinical trials as an anticancer drug. To develop more potent antimicrotubule and cytotoxic derivatives based on the didehydro-DKP skeleton, we performed further modification on the tert-butyl or phenyl groups of 11, and evaluated their cytotoxic and tubulin-binding activities. In the SAR study, we developed more potent derivatives 33 with 2,5-difluorophenyl and 50 with a benzophenone in place of the phenyl group. The anti-HuVEC activity of 33 and 50 exhibited a lowest effective concentration of 2 and 1 nM for microtubule depolymerization, respectively. The values of 33 and 50 were 5 and 10 times more potent than that of CA-4, respectively. These derivatives could be a valuable second-generation derivative with both vascular disrupting and cytotoxic activities.
机译:Plinabulin(11,NPI-2358)是一种有效的微管靶向剂,衍生自天然二酮哌嗪“ phenylahistin”(1),具有类似于秋水仙碱的微管蛋白解聚活性。化合物11最近被开发为VDA,目前正在作为抗癌药进行II期临床试验。为了开发基于二氢-DKP骨架的更有效的抗微管和细胞毒性衍生物,我们对11的叔丁基或苯基进行了进一步修饰,并评估了它们的细胞毒性和微管蛋白结合活性。在SAR研究中,我们开发了更有效的具有2,5-二氟苯基的衍生物33和具有二苯甲酮代替苯基的50衍生物。对于微管解聚,抗HuVEC活性分别为33和50,最低有效浓度分别为2和1 nM。 33和50的值分别比CA-4强5到10倍。这些衍生物可能是有价值的第二代衍生物,具有血管破坏和细胞毒性活性。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号